140 related articles for article (PubMed ID: 38603517)
21. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
[TBL] [Abstract][Full Text] [Related]
22. Association of mast cells and bone marrow reticulin fibrosis in patients with bcr-abl negative chronic myeloproliferative neoplasms.
Keski H
Blood Cells Mol Dis; 2020 May; 82():102420. PubMed ID: 32179412
[TBL] [Abstract][Full Text] [Related]
23. Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.
Hultdin M; Sundström G; Wahlin A; Lundström B; Samuelsson J; Birgegård G; Engström-Laurent A
Med Oncol; 2007; 24(1):63-70. PubMed ID: 17673813
[TBL] [Abstract][Full Text] [Related]
24. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.
Thiele J; Hoeppner B; Zankovich R; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1989; 415(3):191-202. PubMed ID: 2503923
[TBL] [Abstract][Full Text] [Related]
25. Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis.
Colović MD; Wiernik PH; Janković GM; Vidović AD; Janosević S; Basara NM
Eur J Haematol; 1999 Mar; 62(3):155-9. PubMed ID: 10089892
[TBL] [Abstract][Full Text] [Related]
26. STROMAL CHANGES IN LEUKAEMIC AND RELATED BONE MARROW PROLIFERATIONS.
SANERKIN NG
J Clin Pathol; 1964 Sep; 17(5):541-7. PubMed ID: 14207789
[TBL] [Abstract][Full Text] [Related]
27. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
Ellis JT; Peterson P; Geller SA; Rappaport H
Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
[TBL] [Abstract][Full Text] [Related]
28. Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations.
Gur HD; Loghavi S; Garcia-Manero G; Routbort M; Kanagal-Shamanna R; Quesada A; Khogeer H; Pierce S; Medeiros LJ; Kantarjian H; Khoury JD
Am J Surg Pathol; 2018 Jun; 42(6):799-806. PubMed ID: 29596070
[TBL] [Abstract][Full Text] [Related]
29. Study of significance of bone marrow microvessel density in myeloproliferative neoplasms in correlation with CD34 blasts, mast cell count and fibrosis.
Thomas K; Rao R; G V C; Rai S; Rao A R S; Basavaraju Vatsala K
F1000Res; 2023; 12():503. PubMed ID: 38434629
[No Abstract] [Full Text] [Related]
30. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
[TBL] [Abstract][Full Text] [Related]
31. The bone marrow in polycythemia vera.
Ellis JT; Peterson P
Pathol Annu; 1979; 14 Pt 1():383-403. PubMed ID: 390480
[TBL] [Abstract][Full Text] [Related]
32. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
Serrano J; Roman J; Sanchez J; Jimenez A; Castillejo JA; Herrera C; Gonzalez MG; Reina L; Rodriguez MC; Alvarez MA; Maldonado J; Torres A
Blood; 2000 Apr; 95(8):2659-65. PubMed ID: 10753848
[TBL] [Abstract][Full Text] [Related]
33. High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms.
Pozdnyakova O; Wu K; Patki A; Rodig SJ; Thiele J; Hasserjian RP
Mod Pathol; 2014 Nov; 27(11):1447-54. PubMed ID: 24762543
[TBL] [Abstract][Full Text] [Related]
34. Prognostic evaluation of initial bone marrow histopathological features in chronic granulocytic leukemia.
Cervantes F; Rozman C; Feliu E
Acta Haematol; 1989; 82(1):12-5. PubMed ID: 2505469
[TBL] [Abstract][Full Text] [Related]
35. Acute promyelocytic leukemia with increased bone marrow reticulin fibrosis: Description of three cases and review of the literature.
Abou Dalle I; Nassif S; Bazarbachi A
Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):99-104. PubMed ID: 27614232
[TBL] [Abstract][Full Text] [Related]
36. Myeloproliferative Neoplasm or Reactive Process? A Rare Case of Acute Myeloid Leukemia and Transient Posttreatment Megakaryocytic Hyperplasia with JAK-2 Mutation.
Wang S; Yan J; Zhou G; Heintzelman R; Hou JS
Case Rep Hematol; 2016; 2016():6054017. PubMed ID: 27752371
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity identifies genetic changes in chronic myeloid disorders, including myeloproliferative disorders, myelodysplastic syndromes and chronic myelomonocytic leukemia.
O'Malley DP; Orazi A; Dunphy CH; Coleman BR; Marks RA; Wang M; Cheng L
Mod Pathol; 2007 Nov; 20(11):1166-71. PubMed ID: 17704756
[TBL] [Abstract][Full Text] [Related]
38. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
39. Chronic myeloid leukemia manifested during megakaryoblastic crisis.
Wu CD; Medeiros LJ; Miranda RN; Mark HF; Rintels P
South Med J; 1996 Apr; 89(4):422-7. PubMed ID: 8614887
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow hyaluronan and reticulin in patients with malignant disorders.
Sundström G; Hultdin M; Engström-Laurent A; Dahl IM
Med Oncol; 2010 Sep; 27(3):618-23. PubMed ID: 19548126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]